IDEAYA Biosciences, Inc. (IDYA)

NASDAQ: IDYA · Real-Time Price · USD

37.02

+0.78 (2.15%)

Aug 7, 2026, 4:00 PM EDT - Market closed

IDEAYA Biosciences Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	-175.02	-113.7	-274.48	-112.96	-58.66	-49.76
Depreciation & Amortization	4.49	4.59	3.83	4.01	3.52	3.03
Stock-Based Compensation	55.2	46.12	34.75	18.49	11.63	8.24
Other Adjustments	-5.74	-9.98	-23.23	-11.55	-0.7	1.83
Change in Receivables	-	-	-	0.19	0.89	0.77
Changes in Accounts Payable	12.27	2.7	8.28	2.64	1.86	1.17
Changes in Accrued Expenses	13.23	10.43	10.79	1.64	4.57	4.21
Changes in Unearned Revenue	-	-5.97	-	-13.75	-46.48	-23.54
Changes in Other Operating Activities	-0.69	-5.28	-7.53	-3.92	-3.82	-1.73
Operating Cash Flow	-111.66	-71.1	-247.58	-115.22	-87.18	-55.78
Operating Cash Flow Growth	-	-	-	-	-	-

Investing Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Capital Expenditures	-2.21	-2.37	-3.86	-2.37	-3.44	-2.64
Purchases of Investments	-731.17	-607.89	-1,191	-595.98	-255.81	-315
Proceeds from Sale of Investments	640.64	680.23	692.61	439.89	225.85	247.97
Investing Cash Flow	-92.74	69.98	-502.56	-158.46	-33.4	-69.67

Financing Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Issuance of Common Stock	38.59	29.78	677.55	362.72	97.17	145.45
Net Common Stock Issued (Repurchased)	38.59	29.78	677.55	362.72	97.17	145.45
Financing Cash Flow	362.82	29.78	677.55	362.72	97.17	145.45

Net Cash Flow

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Cash Flow	158.42	28.66	-72.59	89.04	-23.41	20.01

Free Cash Flow

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Free Cash Flow	-113.87	-73.47	-251.44	-117.59	-90.62	-58.42
Free Cash Flow Growth	-	-	-	-	-	-
FCF Margin	-48.64%	-33.59%	-3592.01%	-502.85%	-177.92%	-209.09%
Free Cash Flow Per Share	-1.27	-0.83	-3.08	-2.04	-2.19	-1.66
Levered Free Cash Flow	-147.92	-109.61	-262.95	-124.72	-102.44	-69.27
Unlevered Free Cash Flow	-189.86	-155.22	-315.45	-146.19	-106.29	-69.77

SEC Filings: 10-K · 10-Q